Nomilin

Nomilin

SCHEMBL691775

CC(=O)O[C@H]1CC(=O)OC(C)(C)[C@@H]2CC(=O)[C@]3(C)[C@H](CC[C@@]4(C)[C@H](c5ccoc5)OC(=O)[C@H]5O[C@]543)[C@@]12C

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 16/20 0.80
▸ MAPT P10636 4/20 0.80
▸ USP2 O75604 10/20 0.65
▸ SMN1; SMN2 Q16637 4/20 0.65
▸ MAPK1 P28482 1/20 0.64
▸ SLCO1B3 Q9NPD5 3/20 0.63
▸ SLCO1B1 Q9Y6L6 3/20 0.63
▸ ABCB1 P08183 1/20 0.60
▸ RECQL P46063 1/20 0.60
▸ LMNA P02545 2/20 0.59
▸ TP53 P04637 2/20 0.59
▸ APEX1 P27695 1/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nomilin SCHEMBL29387920 1.00 CYP3A4 (0.80) CYP3A4MAPTUSP2SMN1; SMN2MAPK1
SCHEMBL11891055 0.90 CYP3A4 (0.79) CYP3A4MAPTUSP2SMN1; SMN2MAPK1
SCHEMBL10019469 0.89 CYP3A4 (1.00) CYP3A4MAPTUSP2SMN1; SMN2MAPK1
SCHEMBL13424852 0.89 CYP3A4 (1.00) CYP3A4MAPTUSP2SMN1; SMN2MAPK1
SCHEMBL14386278 0.88 CYP3A4 (0.78) CYP3A4MAPTUSP2SMN1; SMN2MAPK1
SCHEMBL14427978 0.88 CYP3A4 (0.78) CYP3A4MAPTUSP2SMN1; SMN2MAPK1
SCHEMBL29385694 0.87 CYP3A4 (0.75) CYP3A4MAPTUSP2SMN1; SMN2MAPK1
SCHEMBL29574101 0.87 CYP3A4 (0.75) CYP3A4MAPTUSP2SMN1; SMN2MAPK1
SCHEMBL18969706 0.87 CYP3A4 (0.75) CYP3A4MAPTUSP2SMN1; SMN2MAPK1
SCHEMBL22039169 0.87 CYP3A4 (0.61) CYP3A4MAPTUSP2SMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119185328-B Application of nomilin in preparation of medicine for improving antiviral immunity of organism 蚌埠医学院第一附属医院 2025-05-13 — — CN claimed
CN-119770502-A Application of nomilin in preparation of medicines for treating and preventing depression 滨州医学院 2025-04-08 — — CN claimed
CN-116148390-B Quality detection method for salt orange core formula particles 长沙新林制药有限公司 2025-03-18 — — CN claimed
CN-119564722-A Stem cell preparation and preparation method thereof 北京鸿心科技有限公司 2025-03-07 — — CN claimed
CN-119470756-A UPLC quantitative fingerprint detection method for camphor head red tangerine peel 赣江中药创新中心 2025-02-18 — — CN claimed
CN-119424344-A Preparation method and quality control method of fingered citron formula particles 成都中医药大学 2025-02-14 — — CN claimed
EP-4015000-B1 COMBINATION PRODUCT CONTAINING LIMONIN COMPOUND AND THIAZOLIDINEDIONE ZHEJIANG YANGSHENGTANG INST OF NATURAL MEDICATION CO LTD (CN) 2025-01-01 — — EP claimed
CN-119185328-A Application of nomilin in preparation of medicine for improving antiviral immunity of organism 蚌埠医学院第一附属医院 2024-12-27 — — CN claimed
CN-119165087-A Method for detecting multiple components in rhizoma coptidis green particles 上海市第七人民医院(上海中医药大学附属第七人民医院) 2024-12-20 — — CN claimed
US-20240397987-A1 COMPOSITION DERIVED FROM CITRUS FRUIT AND BEVERAGE CONTAINING THE SAME SUNTORY HOLDINGS LIMITED (JP) 2024-12-05 — — US claimed
WO-2001051043-A2 COMPOSITIONS AND METHODS FOR TREATMENT OF NEOPLASTIC DISEASES WITH COMBINATIONS OF LIMONOIDS, FLAVONOIDS AND TOCOTRIENOLS KGK SYNERGIZE (US) 2001-07-19 — — WO claimed
US-6251400-B1 COMPRISING LIMONIN AND/OR NOMILIN, AND A TOCOTRIENOL KGK SYNERGIZE INC (CA) 2001-06-26 — — US claimed
US-6239114-B1 TRITERPENE DERIVATIVES, ANTITUMOR KGK SYNERGIZE (CA) 2001-05-29 — — US claimed
WO-2001032160-A2 MODIFICATION OF CHOLESTEROL CONCENTRATIONS WITH CITRUS PHYTOCHEMICALS TROPICANA PRODUCTS, INC. (US) 2001-05-10 — — WO claimed
EP-1049464-A2 USE OF CITRUS LIMONOIDS AND FLAVONOIDS AS WELL AS TOCOTRIENOLS FOR THE TREATMENT OF CANCER KGK Synergize Inc. (CA) 2000-11-08 — — EP claimed
WO-2000006127-A1 CENTERFILL DELIVERY SYSTEM FOR NUTRACEUTICALS WARNER-LAMBERT COMPANY (US) 2000-02-10 — — WO claimed
WO-1999015167-A2 USE OF CITRUS LIMONOIDS AND FLAVONOIDS AS WELL AS TOCOTRIENOLS FOR THE TREATMENT OF CANCER KGK SYNERGIZE INC. (CA) 1999-04-01 — — WO claimed
US-5041425-A Antitumor agent TOYOTAMA PERFUMERY CO., LTD. (JP) 1991-08-20 — — US claimed
US-4479972-A LEMON, ORANGE GENERAL FOODS CORPORATION (US) 1984-10-30 — — US claimed
US-4447456-A ENZYME METABOLISM THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1984-05-08 — — US claimed
Send feedback